Generation of NK cells with chimeric-switch receptors to overcome PD1-mediated inhibition in cancer immunotherapy.
Susek KH, Schwietzer YA, Karvouni M, Gilljam M, Keszei M, Hussain A, Lund J, Kashif M, Lundqvist A, Ljunggren HG, Nahi H, Wagner AK, Alici E.
Susek KH, et al.
Cancer Immunol Immunother. 2023 May;72(5):1153-1167. doi: 10.1007/s00262-022-03317-y. Epub 2022 Nov 10.
Cancer Immunol Immunother. 2023.
PMID: 36355079
Free PMC article.